Sign in
4

Changes in Ownership

RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-005448

CEO sold 10,000 shares at an average $32.39 ($323,914)

  • CEO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

TRAVERSA SERGIO · CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-27 Exercise or conversion : show line 1 in the form +10,000 $3.24 $32,400 85,493 D
2021-01-27 Sale : show line 2 in the form −4,351 $31.77 $138,231 81,142 D
2021-01-27 Sale : show line 3 in the form −5,549 $32.86 $182,340 75,593 D
2021-01-27 Sale : show line 4 in the form −100 $33.43 $3,343 75,493 D
Open-market sales · 10,000 sh · avg $32.39 · $323,914

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-27 Exercise or conversion : show line 5 in the form Options to purchase common stock −10,000 148,422 D
Loading xslF345X03/ownership.xml…